Imfinzi (durvalumab) - AstraZeneca
|
Vectibix (panitumumab) - Amgen
|
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
|
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
|
vorbipiprant (CR6086) - Rottapharm Biotech
|
balstilimab (AGEN2034) - Agenus
|
Lumakras (sotorasib) - Amgen
|
botensilimab (AGEN1181) - Agenus
|